These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7597269)

  • 1. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy.
    Congleton J; Muers MF
    Respir Med; 1995 Apr; 89(4):291-6. PubMed ID: 7597269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH; Luursema PB; Sips AP; Beumer HM; Wald FD; Cornelissen PJ
    Respiration; 1992; 59(6):322-6. PubMed ID: 1488568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction.
    Crane J; Gamble S; Purdie G
    N Z Med J; 1987 Jun; 100(826):385-7. PubMed ID: 2967448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction.
    Barros MJ; Rees PJ
    Respir Med; 1990 Sep; 84(5):371-5. PubMed ID: 2147295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of airflow obstruction and associated breathlessness in normal and asthmatic subjects: correlation with anxiety and bronchodilator needs.
    Boulet LP; Cournoyer I; Deschesnes F; Leblanc P; Nouwen A
    Thorax; 1994 Oct; 49(10):965-70. PubMed ID: 7974312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
    Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC;
    Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator response to inhaled beta-2 agonist and anticholinergic drugs in patients with bronchiectasis.
    Hassan JA; Saadiah S; Roslan H; Zainudin BM
    Respirology; 1999 Dec; 4(4):423-6. PubMed ID: 10612580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved delivery of fenoterol plus ipratropium bromide using Respimat compared with a conventional metered dose inhaler.
    Goldberg J; Freund E; Beckers B; Hinzmann R
    Eur Respir J; 2001 Feb; 17(2):225-32. PubMed ID: 11334124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
    Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
    BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
    Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a mucus clearance device enhances the bronchodilator response in patients with stable COPD.
    Wolkove N; Kamel H; Rotaple M; Baltzan MA
    Chest; 2002 Mar; 121(3):702-7. PubMed ID: 11888949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
    Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation.
    Morrison JF; Jones PC; Muers MF
    Eur Respir J; 1992 Apr; 5(4):424-9. PubMed ID: 1532940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.
    Huchon G; Hofbauer P; Cannizzaro G; Iacono P; Wald F
    Eur Respir J; 2000 Apr; 15(4):663-9. PubMed ID: 10780756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
    Hadcroft J; Calverley PM
    Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy.
    Tashkin DP; Klein GL; Colman SS; Zayed H; Schonfeld WH
    Am J Med; 2007 May; 120(5):435-41. PubMed ID: 17466655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.